Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.

Completed · Not applicable

Conditions studied: Injections, Intradermal

In brief

The purpose of this study is to evaluate whether two intradermal (ID) vaccine delivery devices can safely and precisely inject liquid into the intradermal layer of the skin in three different injection locations

Key facts

Study ID

NCT01943110

Run by

PATH

People needed

30

Starts

2013-07-01

Expected to finish

2013-07-01

Last updated by the study team

2016-03-02

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Female and male participants ages 18 to 55 years.
• Healthy enough to participate in the clinical trial per site investigator assessment.
• Healthy skin on the upper deltoid, suprascapular, and forearm regions (both sides of the body).
• Able to provide signed informed consent and understand study procedures per ICH/GCP guidelines.
• Literate in English.
• Available by telephone 48 hours after the study visit.

You may not qualify if…

• Skin abnormalities on upper deltoid, suprascapular, and forearm regions of either side of the body (scars, rash, infection), tattoo at the injection site, or other skin conditions that would interfere with the ability to visualize an intradermal injection in the opinion of the investigator.

Where it is running

• Rainier Clinical Research Center — Renton, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.